Myofascial Release + Erlotinib
Erlotinib brand name: Tarceva.
We found no known interaction between Myofascial Release and Erlotinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Erlotinib states a food rule worth keeping to.
Myofascial Release and Erlotinib
We checked these two against our interaction database. Here is what we found.
No Known Interaction Found
We did not find a documented interaction between Erlotinib and Myofascial Release in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.
Worth understanding: our licensed dataset holds no drug-interaction record for Myofascial Release at all — not against Erlotinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.
If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.
Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.
Myofascial Release safety at a glance
Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Some Erlotinib Products Have a Food Rule — Myofascial Release Should Not Break It
At least one FDA label for a product containing Erlotinib says to take it on an empty stomach. Most supplements — Myofascial Release included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Erlotinib on its own and move Myofascial Release to a meal later in the day.
This may not be true of your version. Food instructions belong to the product, not the ingredient: two Erlotinib products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.
Recommended Dose – NSCLC The recommended daily dose of erlotinib tablets for NSCLC is 150 mg taken on an empty stomach, i.e., at least one hour before or two hours after the ingestion of food.
From the Dosage and Administration section of the FDA label we read for Erlotinib — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›
A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.
See Every Supplement That Interacts With Erlotinib
This page covers Myofascial Release only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Erlotinib page lists 18 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Activated Charcoal (major), Bilberry (moderate), Coffee Charcoal (moderate), European Mandrake (moderate) and Glucomannan (moderate).
By severity: 1 major · 8 moderate · 9 minor.
From our pharmacist’s overview on the Erlotinib page
“Activated charcoal is the entry I would flag first for anyone taking erlotinib (Tarceva), an oral targeted therapy for certain lung cancers. Charcoal can adsorb the drug in the gut and cut how much reaches the bloodstream, and with a cancer pill, less absorbed means less cancer fought.”
Reviewed by 2 · Jul 18, 2026
Where Myofascial Release and Erlotinib Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#1,193 of 1,452 supplements looked up here in the last 7 days
#1,781 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
Where does our data come from?
- Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Myofascial Release is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
- Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Myofascial Release reference on this page ↓
- Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Myofascial Release and Erlotinib records this page draws on were last updated June 20, 2026.
- What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
About Myofascial Release
What is Myofascial Release?
- Muscle tightness and pain
- Back and neck pain
- Limited range of motion
- Fibromyalgia symptoms
- Tension headaches
- Sports recovery
Myofascial release is a hands-on (or self-applied) manual therapy that uses gentle, sustained pressure to ease muscle and connective tissue tightness. It is not a supplement or herb, and while many people find it helpful for muscle pain and stiffness, the scientific evidence is mixed and limited. It is generally low-risk when done properly, but talk to a doctor or physical therapist before starting, especially if you have a medical condition.
Not applicable (manual therapy technique) · Hands-on therapy, foam rolling, massage balls, instrument-assisted tools
An interaction check asks whether these two react with each other — it does not ask whether Myofascial Release is a good idea for someone in your situation. Here is what our Myofascial Release record says about it on its own.
Myofascial Release: dosing
Because myofascial release is a manual therapy and not a supplement, there is no standardized "dose" in milligrams or pills. Treatment plans vary based on your needs, your provider, and your condition.In professional settings, sessions may last anywhere from a few minutes to an hour, and how often you go depends on your goals. For at-home self-release with a foam roller or ball, start gently and for short periods, and avoid rolling directly over joints, bones, or injured areas. Follow the guidance of a qualified physical therapist or provider, and check with a healthcare professional before starting a new routine.
From our Myofascial Release monograph — the full record covers uses, side effects and every documented interaction.
About Erlotinib
What Is Erlotinib Used For?
Brand name: Tarceva
Erlotinib tablets are used to treat metastatic non-small cell lung cancer (NSCLC) in patients whose tumors carry specific gene changes — EGFR exon 19 deletions or exon 21 (L858R) mutations — confirmed by an FDA-approved test. It can be used as a first-line treatment, as maintenance therapy, or after at least one prior chemotherapy has stopped working.
Erlotinib tablets are also used for the first-line treatment of locally advanced, unresectable, or metastatic pancreatic cancer — but only in combination with another chemotherapy drug called gemcitabine. Erlotinib is not recommended alongside platinum-based chemotherapy regimens.
Most-Reported Side Effects for Erlotinib
From FAERS, the FDA’s public side-effect reporting system (12,442 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.
Other Drugs & Myofascial Release
Browse every other medication we’ve checked against Myofascial Release — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
No interaction 2,829 drugs checked — show the list
We also checked Myofascial Release against these medications and found no known interaction in our sources. Open any page to confirm.
- Apixaban ›
- Levothyroxine ›
- Amlodipine ›
- Methylphenidate ›
- Warfarin ›
- Sertraline ›
- Testosterone ›
- Losartan Potassium ›
- Ivermectin ›
- Metoprolol ›
- Aspirin ›
- Rivaroxaban ›
- Rosuvastatin ›
- Acetaminophen ›
- Escitalopram ›
- Abemaciclib ›
- Tadalafil ›
- Clopidogrel ›
- Atorvastatin ›
- Docusate ›
- Hydroxyurea ›
- Valacyclovir ›
- Ibuprofen ›
- Methamphetamine ›
- Tirzepatide ›
- Warfarin Sodium ›
- Semaglutide ›
- Sumatriptan ›
- Prednisone ›
- Propranolol ›
- Lisdexamfetamine ›
- Metformin ›
- Lisinopril ›
- Amoxicillin ›
- Bupropion ›
- Amitriptyline ›
- Bendamustine ›
- Acyclovir ›
- Methotrexate ›
- Doxycycline ›
- Fluoxetine ›
- Amphetamine ›
- Pregabalin ›
- Lamotrigine ›
- Acetaminophen, Codeine ›
- Azithromycin ›
- Gabapentin ›
- Isotretinoin ›
- Dextroamphetamine ›
- Amlodipine Besylate ›
- Clonazepam ›
- Methylene Blue ›
- Omeprazole ›
- Quetiapine ›
- Letrozole ›
- Duloxetine ›
- Naproxen ›
- Buspirone ›
- Citalopram ›
- Ciprofloxacin ›
Showing the 60 most looked-up of 2,829 medications checked with no known interaction — see the full Myofascial Release list.
Myofascial Release References
The 2 sources that drive our Myofascial Release monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Myofascial Release is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.
- Massage Therapy: What You Need To Know — NIH NCCIH Source
- Myofascial Release Therapy — Cleveland Clinic Source
Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
Taking Myofascial Release and Erlotinib Together: Common Questions
Is it safe to take Myofascial Release with Erlotinib?
Should I take Myofascial Release and Erlotinib at the same time of day?
Does Erlotinib interact with any supplements?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Keep Exploring
Still Have a Question About Erlotinib and Myofascial Release?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.